Immutep Ltd ADR (IMMP) - Net Assets

Latest as of December 2025: $98.90 Million USD

Based on the latest financial reports, Immutep Ltd ADR (IMMP) has net assets worth $98.90 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($147.20 Million) and total liabilities ($48.30 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Immutep Ltd ADR (IMMP) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	$98.90 Million
% of Total Assets	67.19%
Annual Growth Rate	26.52%
5-Year Change	96.03%
10-Year Change	306.7%
Growth Volatility	199.28

Immutep Ltd ADR - Net Assets Trend (2008–2025)

This chart illustrates how Immutep Ltd ADR's net assets have evolved over time, based on quarterly financial data. Also explore IMMP current and non-current assets for the complete picture of this company's asset base.

Annual Net Assets for Immutep Ltd ADR (2008–2025)

The table below shows the annual net assets of Immutep Ltd ADR from 2008 to 2025. For live valuation and market cap data, see Immutep Ltd ADR market capitalisation.

Year	Net Assets	Change
2025-06-30	$143.64 Million	-24.21%
2024-06-30	$189.52 Million	+38.87%
2023-06-30	$136.47 Million	+45.06%
2022-06-30	$94.08 Million	+28.40%
2021-06-30	$73.27 Million	+120.04%
2020-06-30	$33.30 Million	+36.54%
2019-06-30	$24.39 Million	-27.25%
2018-06-30	$33.52 Million	+26.34%
2017-06-30	$26.53 Million	-24.87%
2016-06-30	$35.32 Million	+43.05%
2015-06-30	$24.69 Million	+9.28%
2014-06-30	$22.59 Million	-22.76%
2013-06-30	$29.25 Million	-21.29%
2012-06-30	$37.16 Million	-32.56%
2011-06-30	$55.10 Million	+228.21%
2010-06-30	$16.79 Million	+826.20%
2009-06-30	$1.81 Million	-31.17%
2008-06-30	$2.63 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Immutep Ltd ADR's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 40822932400.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component	Amount	Percentage
Common Stock	$535.07 Million	372.52%
Other Comprehensive Income	$52.65 Million	36.65%
Other Components	$1.00	0.00%
Total Equity	$143.64 Million	100.00%

Immutep Ltd ADR Competitors by Market Cap

The table below lists competitors of Immutep Ltd ADR ranked by their market capitalization.

Company	Market Cap
Afarak Group Oyj HE:AFAGR	$84.04 Million
CAG Group AB (publ) ST:CAG	$84.08 Million
Stealth Group Holdings Ltd AU:SGI	$84.13 Million
Wrap Technologies Inc NASDAQ:WRAP	$84.13 Million
Atrium Real Estate Investment Trust KLSE:5130	$84.01 Million
Nova Minerals Limited NYSE MKT:NVA	$83.98 Million
Roo Hsing Co Ltd TW:4414	$83.94 Million
MFEC PCL BK:MFEC	$83.93 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Immutep Ltd ADR's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 189,521,742 to 143,635,363, a change of -45,886,379 (-24.2%).
Net loss of 61,434,165 reduced equity.
Other comprehensive income increased equity by 22,583,096.
Other factors decreased equity by 7,035,310.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	$-61.43 Million	-42.77%
Other Comprehensive Income	$22.58 Million	+15.72%
Other Changes	$-7.04 Million	-4.9%
Total Change	$-	-24.21%

Book Value vs Market Value Analysis

This analysis compares Immutep Ltd ADR's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.58x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 9.25x to 0.58x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2008-06-30	$0.06	$0.57	x
2009-06-30	$0.04	$0.57	x
2010-06-30	$0.39	$0.57	x
2011-06-30	$1.29	$0.57	x
2012-06-30	$0.87	$0.57	x
2013-06-30	$0.69	$0.57	x
2014-06-30	$0.53	$0.57	x
2015-06-30	$0.58	$0.57	x
2016-06-30	$1.55	$0.57	x
2017-06-30	$0.62	$0.57	x
2018-06-30	$0.79	$0.57	x
2019-06-30	$0.07	$0.57	x
2020-06-30	$0.82	$0.57	x
2021-06-30	$1.21	$0.57	x
2022-06-30	$1.09	$0.57	x
2023-06-30	$1.52	$0.57	x
2024-06-30	$1.58	$0.57	x
2025-06-30	$0.99	$0.57	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Immutep Ltd ADR utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -42.77%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -1218.02%
• Asset Turnover: 0.03x
• Equity Multiplier: 1.09x
Recent ROE (-42.77%) is above the historical average (-64.75%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2008	-71.67%	0.00%	0.00x	1.07x	$-2.15 Million
2009	-162.53%	0.00%	0.00x	1.37x	$-3.13 Million
2010	-72.43%	-2321.57%	0.03x	1.13x	$-13.84 Million
2011	-38.26%	0.00%	0.00x	1.05x	$-26.59 Million
2012	-53.67%	-1311.89%	0.04x	1.12x	$-23.66 Million
2013	-52.06%	-380.13%	0.12x	1.12x	$-18.15 Million
2014	-59.06%	-424.94%	0.12x	1.12x	$-15.60 Million
2015	-130.22%	-1536.25%	0.07x	1.25x	$-34.62 Million
2016	-175.59%	-35426.72%	0.00x	1.20x	$-65.55 Million
2017	-35.30%	-221.89%	0.12x	1.32x	$-12.02 Million
2018	-38.02%	-484.55%	0.06x	1.40x	$-16.10 Million
2019	-66.72%	-11640.01%	0.00x	1.66x	$-18.71 Million
2020	-40.45%	-179.90%	0.16x	1.40x	$-16.80 Million
2021	-40.81%	-774.12%	0.05x	1.12x	$-37.23 Million
2022	-34.24%	-18906.51%	0.00x	1.09x	$-41.62 Million
2023	-29.23%	-1138.04%	0.02x	1.08x	$-53.54 Million
2024	-22.54%	-1111.87%	0.02x	1.06x	$-61.67 Million
2025	-42.77%	-1218.02%	0.03x	1.09x	$-75.80 Million

Industry Comparison

This section compares Immutep Ltd ADR's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $44,828,400
Average return on equity (ROE) among peers: -124.18%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Immutep Ltd ADR (IMMP)	$98.90 Million	-71.67%	0.49x	$84.03 Million
Aardvark Therapeutics, Inc. Common Stock (AARD)	$-54.64 Million	0.00%	0.00x	$118.88 Million
Abcellera Biologics Inc (ABCL)	$10.25 Million	-21.57%	1.29x	$1.07 Billion
Abeona Therapeutics Inc (ABEO)	$3.60 Million	-91.89%	0.28x	$292.09 Million
Acumen Pharmaceuticals Inc (ABOS)	$266.97 Million	-19.62%	0.16x	$171.87 Million
Abpro Holdings, Inc. (ABP)	$3.07 Million	-479.81%	1.57x	$448.19K
Absci Corp (ABSI)	$67.00 Million	-21.42%	0.32x	$345.85 Million
Arbutus Biopharma Corp (ABUS)	$88.00 Million	-44.09%	0.34x	$840.56 Million
ABVC Biopharma Inc (ABVC)	$80.00K	-31.70%	0.38x	$26.41 Million
Abivax SA American Depositary Shares (ABVX)	$40.58 Million	-434.26%	4.06x	$9.33 Billion
ACADIA Pharmaceuticals Inc (ACAD)	$23.36 Million	-97.44%	0.37x	$3.74 Billion

About Immutep Ltd ADR

NASDAQ:IMMP USA Biotechnology

Market Cap

$84.03 Million

Market Cap Rank

#19840 Global

#4309 in USA

Share Price

$0.57

Change (1 day)

-3.65%

52-Week Range

$0.31 - $3.18

All Time High

$5.69